VEGFA and glioblastoma: Indeed, dual inhibition of Ang-2 and VEGF in a murine glioblastoma model with highly abnormal tumor vessels decreased vessel density and reprogrammed TAMs toward an anti-tumor phenotype and improved the therapeutic efficacy of anti-VEGF monotherapy [120].